stars 1 stars 2 stars 3

Avectas is accelerating the future of cell therapy with a flexible, easy-to-integrate delivery platform that manufactures healthier and more functional cells for patients. Excelling at complex editing and challenging cargo delivery, the Avectas non-viral delivery platform ensures the next generation of cell therapies can be realized. The Solupore non-viral delivery system enables the next generation of cell therapies through unparalleled cell health and superior cell functionality, expanding the possibilities for complex editing and challenging cargo delivery. Easy to integrate into existing GMP processes, Solupore accelerates the translation of life-saving therapies to patients.

View Top Employees from Avectas
Website http://www.avectas.com
Employees 50 (50 on RocketReach)
Founded 2011
Technologies
Industry Biotechnology Research, Cell Engineering, Transfection, Cell Therapy, CAR-T, Gene Editing, Gene Therapy, CRISPR

Avectas Questions

Lisa O'Flynn is the Senior Director of Process and Analytical Development of Avectas.

50 people are employed at Avectas.

Top Avectas Employees

View Similar People
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups / month.
Search
Search over 700 million verified professionals across 35 million companies.
Get Contact Info
Get contact details including emails and phone numbers (business & personal).
High Performer Summer 2022 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2 RocketReach is a leader in Lead Intelligence on G2
talentculture2022
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users